ETH researchers working with Martin Fussenegger have developed an early warning system for the four most common types of cancer. Should a tumour develop, a visible mole will appear on the skin.
Alongside cardiovascular disease, cancer has become the top cause of death in industrialised countries. Many of those affected are diagnosed only after the tumour has developed extensively. This often reduces the chance of recovery significantly: the cure rate for prostate cancer is 32 percent and only 11 percent for colon cancer. The ability to detect such tumours reliably and early would not only save lives, but also reduce the need for expensive, stressful treatment.
Researchers working with Martin Fussenegger, Professor at the Department of Biosystems Science and Engineering at ETH Zurich in Basel, have now presented a possible solution for this problem: a synthetic gene network that serves as an early warning system. It recognises the four most common types of cancer – prostate, lung, colon and breast cancer – at a very early stage, namely when the level of calcium in the blood is elevated due to the developing tumour.
Derailed calcium balance triggers melanin production
The early warning system comprises a genetic network that biotechnologists integrate into human body cells, which in turn are inserted into an implant. This encapsulated gene network is then implanted under the skin where it constantly monitors the blood calcium level.
As soon as the calcium level exceeds a particular threshold value over a longer period of time, a signal cascade is triggered that initiates production of the body’s tanning pigment melanin in the genetically modified cells. The skin then forms a brown mole that is visible to the naked eye.
The mole appears long before the cancer becomes detectable through conventional diagnosis. “An implant carrier should then see a doctor for further evaluation after the mole appears,” explains Fussenegger. It is no reason to panic. “The mole does not mean that the person is likely to die soon,” stresses the ETH professor. It simply means that clarification and if necessary treatment are needed.
The researchers used calcium as the indicator of the development of the four types of cancer, as it is regulated strongly in the body. Bones serve as a buffer that can balance out concentration differences. However, when too much calcium is detected in the blood, this may serve as a sign for one of the four cancers.
Early detection increases survival rate
“Early detection increases the chance of survival significantly,” says Fussenegger. For example, if breast cancer is detected early, the chance of recovery is 98 percent; however, if the tumour is diagnosed too late, only one in four women has a good chance of recovery. “Nowadays, people generally go to the doctor only when the tumour begins to cause problems. Unfortunately, by that point it is often too late.”
The implant also has an additional advantage: “It is intended primarily for self-monitoring, making it very cost effective,” explains the ETH professor. However, for those who would prefer not to deal with the constant stress, an implant can also be used that develops a mark visible only under a red light. “This regular check could be carried out by their doctor.”
The disadvantage is that the service life of such an implant is limited, as Fussenegger has found in literature. “Encapsulated living cells last for about a year, according to other studies. After that, they must be inactivated and replaced.”
A reliable prototype
So far, this early warning implant is a prototype; the associated work recently published in the journal Science Translational Medicine is a feasibility study. The researchers have tested their early warning system in a mouse model and on pig skin. It functioned reliably during these tests. Moles developed only when the calcium concentration reached a high level.
The Basel-based scientists still have a long way to go before human testing can begin. “Continued development and clinical trials in particular are laborious and expensive, which we as a research group cannot afford,” says the ETH professor. However, he would like to promote the translation of his developments, so that one day they will lead to applicable products. He estimates that bringing such a cancer diagnosis implant to market maturity will take at least ten years of research and development.
The concept of the “biomedical tattoo”, as Fussenegger describes this new finding, would also be applicable to other gradually developing illnesses, such as neurodegenerative diseases and hormonal disorders. In principle, the researchers could replace the molecular sensor to measure biomarkers other than calcium.
Learn more: An artificial mole as an early warning sign
The Latest on: Synthetic gene network
via Google News
The Latest on: Synthetic gene network
- ICC Makes Strategic Investment in Disruptive Biosynthesis Research -- CFN Media on April 16, 2019 at 6:00 am
SEATTLE, April 16, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the ... Recent advancements in the areas of ... […]
- Inside Arzeda’s synthetic biology lab, where industrial ingredients are brewed like beer on April 16, 2019 at 12:00 am
Zanghellini’s job, as the CEO of Seattle-based synthetic biology company Arzeda ... Behind the building is a network of train tracks where the fuselages of Boeing jets sit waiting to be transported. ... […]
- The Promise and Perils of Synthetic Biology on April 8, 2019 at 12:37 pm
For the past four billion years or so the only way for life on Earth to produce a sequence of DNA — a gene — was ... The earliest stages of such “synthetic biology” are already ... […]
- Researchers develop gene circuit design strategy to advance synthetic biology on August 7, 2018 at 9:58 am
(Nanowerk News) Over the last 17 years, scientists and engineers have developed synthetic gene circuits ... the quantitative understanding of gene circuit behaviors, and facilitates the transformation ... […]
- Programming gene and engineered-cell therapies with synthetic biology on April 27, 2018 at 5:32 am
... build gene circuits that behave as anticipated (79), often requiring many design-build-test iterations before a synthetic gene network meets its performance goals. One common reason is unaccounted ... […]
- Synthetic cancer indicator: An artificial mole as an early warning system on April 19, 2018 at 8:12 am
Researchers working with Martin Fussenegger, Professor at the Department of Biosystems Science and Engineering at ETH Zurich in Basel, have now presented a possible solution for this problem: a ... […]
- Gene circuit design strategy to advance synthetic biology on September 27, 2017 at 12:48 pm
According to Lu, this work advances the quantitative understanding of gene circuit behaviors, and facilitates the transformation of gene network design ... College of Engineering. "Gene circuit design ... […]
- Team develops gene circuit design strategy to advance synthetic biology on September 26, 2017 at 12:58 pm
Over the last 17 years, scientists and engineers have developed synthetic gene circuits that ... advances the quantitative understanding of gene circuit behaviors, and facilitates the transformation ... […]
- An integrative circuit–host modelling framework for predicting synthetic gene network behaviours on September 25, 2017 at 8:05 am
One fundamental challenge in synthetic biology is the lack of quantitative tools that accurately describe and predict the behaviours of engineered gene circuits. This challenge arises from multiple ... […]
via Bing News